A2 Milk could benefit as Abbott pulls out of Chinese infant formula market

A2 Milk could benefit as Abbott pulls out of Chinese infant formula market
The US company's market share in China will be up for grabs. (Image: Getty)
Rebecca Howard
A2 Milk stands to benefit as US-based healthcare firm Abbott Laboratories phases out its infant and child nutrition business in China, but the news also underscores how tough that market is.Abbott will gradually stop making and selling baby formula under the Eleva, PediaSure, and Similac brands as well as the sub-brands of Total Comfort and NeoSure, it said on WeChat, according to news service Yicai Global.In the English translation of an internal email seen by BusinessDesk, company executives said it was a “difficult decision” that...

More Primary Sector

Port of Tauranga ‘reluctantly’ doubles MetroPort rail fees
Primary Sector

Port of Tauranga ‘reluctantly’ doubles MetroPort rail fees

The port says it's working with KiwiRail on 'long-term arrangements'. 

Oliver Lewis 04 Jul 2025
BX Foods settles director disputes, posts $7.9m loss
Primary Sector

BX Foods settles director disputes, posts $7.9m loss

The Chinese-owned food company removed three executives, alleging fiduciary breaches.

Riley Kennedy 03 Jul 2025